{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:57:23Z","timestamp":1786982243468,"version":"build-2736575974"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s12072-017-9840-z","type":"journal-article","created":{"date-parts":[[2018,1,9]],"date-time":"2018-01-09T03:55:16Z","timestamp":1515470116000},"page":"37-43","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["The utility of noninvasive scores in assessing the prevalence of nonalcoholic fatty liver disease and advanced fibrosis in type 1 diabetic patients"],"prefix":"10.1007","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8581-1408","authenticated-orcid":false,"given":"Amandeep","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phuc","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocio","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naim","family":"Alkhouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,9]]},"reference":[{"issue":"7","key":"9840_CR1","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1053\/j.gastro.2012.04.001","volume":"142","author":"N Chalasani","year":"2012","unstructured":"Chalasani N, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology 2012;142(7):1592\u2013609.","journal-title":"Gastroenterology"},{"issue":"1","key":"9840_CR2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/ATVBAHA.107.147538","volume":"28","author":"A Kotronen","year":"2008","unstructured":"Kotronen A, Yki-Jarvinen H. Fatty liver: a novel component of the metabolic syndrome. Arterioscler Thromb Vasc Biol 2008;28(1):27\u201338.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"11","key":"9840_CR3","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nrgastro.2013.149","volume":"10","author":"A Wree","year":"2013","unstructured":"Wree A, et al. From NAFLD to NASH to cirrhosis-new insights into disease mechanisms. Nat Rev Gastroenterol Hepatol 2013;10(11):627\u201336.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"9840_CR4","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.cgh.2011.03.020","volume":"9","author":"ZM Younossi","year":"2011","unstructured":"Younossi ZM, et al. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol 2011;9(6):524\u2013530 e1 (quiz e60).","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"9840_CR5","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.2337\/dc10-2229","volume":"34","author":"RM Williamson","year":"2011","unstructured":"Williamson RM, et al. Prevalence of and risk factors for hepatic steatosis and nonalcoholic fatty liver disease in people with type 2 diabetes: the edinburgh type 2 diabetes study. Diabetes Care 2011;34(5):1139\u201344.","journal-title":"Diabetes Care"},{"issue":"4","key":"9840_CR6","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.jhep.2010.04.030","volume":"53","author":"G Targher","year":"2010","unstructured":"Targher G, et al. Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes. J Hepatol 2010;53(4):713\u20138.","journal-title":"J Hepatol"},{"issue":"2","key":"9840_CR7","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1464-5491.2011.03427.x","volume":"29","author":"G Targher","year":"2012","unstructured":"Targher G, et al. Increased prevalence of chronic kidney disease in patients with type 1 diabetes and non-alcoholic fatty liver. Diabet Med 2012;29(2):220\u20136.","journal-title":"Diabet Med"},{"issue":"6","key":"9840_CR8","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrgastro.2013.41","volume":"10","author":"QM Anstee","year":"2013","unstructured":"Anstee QM, Targher G, Day CP. Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. Nat Rev Gastroenterol Hepatol 2013;10(6):330\u201344.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"9840_CR9","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1002\/hep.510300604","volume":"30","author":"P Angulo","year":"1999","unstructured":"Angulo P, et al. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999;30(6):1356\u201362.","journal-title":"Hepatology"},{"issue":"11","key":"9840_CR10","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.cgh.2009.06.007","volume":"7","author":"N Hossain","year":"2009","unstructured":"Hossain N, et al. Independent predictors of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2009;7(11):1224\u20139 (1229.e1\u20132).","journal-title":"Clin Gastroenterol Hepatol"},{"key":"9840_CR11","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ijcard.2016.10.040","volume":"225","author":"A Mantovani","year":"2016","unstructured":"Mantovani A, et al. Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular disease in adult patients with type 1 diabetes. Int J Cardiol 2016;225:387\u201391.","journal-title":"Int J Cardiol"},{"issue":"6","key":"9840_CR12","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.jdiacomp.2017.01.024","volume":"31","author":"A Mantovani","year":"2017","unstructured":"Mantovani A, et al. Nonalcoholic fatty liver disease is associated with an increased prevalence of distal symmetric polyneuropathy in adult patients with type 1 diabetes. J Diabetes Complications 2017;31(6):1021\u20136.","journal-title":"J Diabetes Complications"},{"issue":"6","key":"9840_CR13","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.2337\/dc13-2704","volume":"37","author":"G Targher","year":"2014","unstructured":"Targher G, et al. Nonalcoholic fatty liver disease is independently associated with an increased incidence of chronic kidney disease in patients with type 1 diabetes. Diabetes Care 2014;37(6):1729\u201336.","journal-title":"Diabetes Care"},{"issue":"9","key":"9840_CR14","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1111\/j.1478-3231.2007.01592.x","volume":"27","author":"Al Knawy","year":"2007","unstructured":"Knawy Al, Shiffman BM. Percutaneous liver biopsy in clinical practice. Liver Int 2007;27(9):1166\u201373.","journal-title":"Liver Int"},{"issue":"3","key":"9840_CR15","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1053\/gast.2002.35354","volume":"123","author":"S Saadeh","year":"2002","unstructured":"Saadeh S, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002;123(3):745\u201350.","journal-title":"Gastroenterology"},{"issue":"7","key":"9840_CR16","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.dld.2009.08.002","volume":"42","author":"JH Lee","year":"2010","unstructured":"Lee JH, et al. Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Dig Liver Dis 2010;42(7):503\u20138.","journal-title":"Dig Liver Dis"},{"issue":"9","key":"9840_CR17","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1136\/gut.2010.216077","volume":"59","author":"S McPherson","year":"2010","unstructured":"McPherson S, et al. Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease. Gut 2010;59(9):1265\u20139.","journal-title":"Gut"},{"issue":"2","key":"9840_CR18","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","volume":"38","author":"CT Wai","year":"2003","unstructured":"Wai CT, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003;38(2):518\u201326.","journal-title":"Hepatology"},{"issue":"3","key":"9840_CR19","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S0016-5085(88)80022-2","volume":"95","author":"AL Williams","year":"1988","unstructured":"Williams AL, Hoofnagle JH. Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis. Relationship to cirrhosis. Gastroenterology 1988;95(3):734\u20139.","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"9840_CR20","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.2337\/dc17-S005","volume":"40","author":"American Diabetes, A.","year":"2017","unstructured":"American Diabetes, A. (2) Classification and diagnosis of diabetes. Diabetes Care 2017;40(Suppl 1):S11\u201324.","journal-title":"Diabetes Care"},{"issue":"6","key":"9840_CR21","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.25762","volume":"55","author":"N Chalasani","year":"2012","unstructured":"Chalasani N, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 2012;55(6):2005\u201323.","journal-title":"Hepatology"},{"issue":"7","key":"9840_CR22","doi-asserted-by":"crossref","first-page":"e38346","DOI":"10.5812\/hepatmon.38346","volume":"16","author":"HI Fallatah","year":"2016","unstructured":"Fallatah HI, Akbar HO, Fallatah AM. Fibroscan compared to FIB-4, APRI, and AST\/ALT ratio for assessment of liver fibrosis in saudi patients with nonalcoholic fatty liver disease. Hepat Mon 2016;16(7):e38346.","journal-title":"Hepat Mon"},{"issue":"3","key":"9840_CR23","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/hep.22429","volume":"48","author":"AL Fracanzani","year":"2008","unstructured":"Fracanzani AL, et al. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes. Hepatology 2008;48(3):792\u20138.","journal-title":"Hepatology"},{"issue":"9","key":"9840_CR24","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1172\/JCI0215593","volume":"109","author":"JD Horton","year":"2002","unstructured":"Horton JD, Goldstein JL, Brown MS. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 2002;109(9):1125\u201331.","journal-title":"J Clin Invest"},{"issue":"Pt 2","key":"9840_CR25","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1042\/bj3500389","volume":"350","author":"D Azzout-Marniche","year":"2000","unstructured":"Azzout-Marniche D, et al. Insulin effects on sterol regulatory-element-binding protein-1c (SREBP-1c) transcriptional activity in rat hepatocytes. Biochea J 2000;350(Pt 2):389\u201393.","journal-title":"Biochea J"},{"issue":"6","key":"9840_CR26","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.2337\/diabetes.54.6.1684","volume":"54","author":"SS Im","year":"2005","unstructured":"Im SS, et al. Glucose-stimulated upregulation of GLUT2 gene is mediated by sterol response element-binding protein-1c in the hepatocytes. Diabetes 2005;54(6):1684\u201391.","journal-title":"Diabetes"},{"issue":"5","key":"9840_CR27","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.diabet.2009.04.004","volume":"35","author":"B Verges","year":"2009","unstructured":"Verges B. Lipid disorders in type 1 diabetes. Diabetes Metab 2009;35(5):353\u201360.","journal-title":"Diabetes Metab"},{"issue":"4","key":"9840_CR28","doi-asserted-by":"crossref","first-page":"610","DOI":"10.2337\/diacare.21.4.610","volume":"21","author":"JR Erbey","year":"1998","unstructured":"Erbey JR, et al. The association between a family history of type 2 diabetes and coronary artery disease in a type 1 diabetes population. Diabetes Care 1998;21(4):610\u20134.","journal-title":"Diabetes Care"},{"issue":"3","key":"9840_CR29","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2337\/dc06-1982","volume":"30","author":"ES Kilpatrick","year":"2007","unstructured":"Kilpatrick ES, Rigby AS, Atkin SL. Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes: \u201cdouble diabetes\u201d in the diabetes control and complications trial. Diabetes Care 2007;30(3):707\u201312.","journal-title":"Diabetes Care"},{"issue":"1","key":"9840_CR30","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jhep.2004.09.012","volume":"42","author":"LA Adams","year":"2005","unstructured":"Adams LA, et al. The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. J Hepatol 2005;42(1):132\u20138.","journal-title":"J Hepatol"},{"key":"9840_CR31","doi-asserted-by":"crossref","first-page":"570356","DOI":"10.1155\/2015\/570356","volume":"2015","author":"L Miele","year":"2015","unstructured":"Miele L, et al. Diabetes and insulin therapy, but not metformin, are related to hepatocellular cancer risk. Gastroenterol Res Pract 2015;2015:570356.","journal-title":"Gastroenterol Res Pract"},{"issue":"8","key":"9840_CR32","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/nrendo.2011.72","volume":"7","author":"BW Smith","year":"2011","unstructured":"Smith BW, Adams LA. Nonalcoholic fatty liver disease and diabetes mellitus: pathogenesis and treatment. Nat Rev Endocrinol 2011;7(8):456\u201365.","journal-title":"Nat Rev Endocrinol"},{"issue":"5","key":"9840_CR33","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/hep.1840120505","volume":"12","author":"IR Wanless","year":"1990","unstructured":"Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology 1990;12(5):1106\u201310.","journal-title":"Hepatology"},{"issue":"5","key":"9840_CR34","first-page":"535","volume":"35","author":"G Targher","year":"2012","unstructured":"Targher G, et al. Increased prevalence of cardiovascular disease in type 1 diabetic patients with non-alcoholic fatty liver disease. J Endocrinol Invest 2012;35(5):535\u201340.","journal-title":"J Endocrinol Invest"},{"issue":"6","key":"9840_CR35","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","volume":"64","author":"European Association for the Study of the, L., D. European Association for the Study of, and O. European Association for the Study of","year":"2016","unstructured":"European Association for the Study of the, L., D. European Association for the Study of, and O. European Association for the Study of. EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol 2016;64(6):1388\u2013402.","journal-title":"J Hepatol"},{"issue":"8","key":"9840_CR36","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.metabol.2016.01.013","volume":"65","author":"N Alkhouri","year":"2016","unstructured":"Alkhouri N, Feldstein AE. Noninvasive diagnosis of nonalcoholic fatty liver disease: are we there yet ?. Metabolism 2016;65(8):1087\u201395.","journal-title":"Metabolism"},{"issue":"8","key":"9840_CR37","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3109\/07853890.2010.518623","volume":"43","author":"G Musso","year":"2011","unstructured":"Musso G, et al. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med 2011;43(8):617\u201349.","journal-title":"Ann Med"},{"issue":"6","key":"9840_CR38","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1053\/jhep.2003.50229","volume":"37","author":"P Mofrad","year":"2003","unstructured":"Mofrad P, et al. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology 2003;37(6):1286\u201392.","journal-title":"Hepatology"},{"issue":"1","key":"9840_CR39","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.numecd.2006.08.004","volume":"17","author":"S Moscatiello","year":"2007","unstructured":"Moscatiello S, Manini R, Marchesini G. Diabetes and liver disease: an ominous association. Nutr Metab Cardiovasc Dis 2007;17(1):63\u201370.","journal-title":"Nutr Metab Cardiovasc Dis"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12072-017-9840-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-017-9840-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-017-9840-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,2,15]],"date-time":"2018-02-15T12:21:36Z","timestamp":1518697296000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12072-017-9840-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["9840"],"URL":"https:\/\/doi.org\/10.1007\/s12072-017-9840-z","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1]]}}}